An FDA final guidance recommends a skin allergy warning on OTC monograph acetaminophen products that the Consumer Healthcare Products Association contends should be made in more formal rulemaking, even though most of the products now marketed already include the language.
The agency did not agree with CHPA's contention and on Jan. 11 published a
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?